In Brief: Merck To Invest $1bn In New US Biologics Production

 
• By Sushmita Panda
  
Merck faces heightened tariff risk. (Shutterstock)
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Manufacturing

More from Scrip